Drug intelligence / Profile preview

Codaewon Plus

Development stage
Phase 3
Lead developer
Daewon Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Codaewon Plus is a multi-component combination syrup developed by Daewon Pharmaceutical for the treatment of acute bronchitis and its associated symptoms, such as cough and phlegm. The formulation combines the antitussive, bronchodilatory, antihistaminic, and expectorant properties of the 'Codaewon Forte' formulation (comprising dihydrocodeine bitartrate, dl-methylephedrine hydrochloride, chlorpheniramine maleate, and guaifenesin) with the antimicrobial and immunomodulatory effects of *Pelargonium sidoides* extract. This synergistic approach aims to provide comprehensive symptom relief while potentially addressing the underlying viral or bacterial causes of respiratory distress. It was approved in South Korea in 2020 as the first product to combine a dihydrocodeine-based syrup with *Pelargonium sidoides* extract.

Brand names
Codaewon Plus
Other names
DW-5121DW5121DW 5121코대원플러스
02

Targets

HRH1 (Histamine H1 Receptor)ADRB1 (β1)ADRA1A (α1A)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Codaewon Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Codaewon Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call